About Azurity Pharmaceuticals
Azurity Pharmaceuticals is a company based in Woburn (United States) founded in 1999. Azurity Pharmaceuticals has raised $20 million across 1 funding round from investors including Ampersand Capital Partners. Azurity Pharmaceuticals has completed 4 acquisitions, including Arbor pharma, Covis Pharma and Silvergate Pharma. Azurity Pharmaceuticals offers products and services including XIFYRM and FIRVANQ.
- Headquarter Woburn, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Azurity Pharmaceuticals, Inc
-
Annual Revenue
$64.85 K (USD)-33as on Jul 26, 2023
-
Net Profit
$40.74 K (USD)-41as on Jul 26, 2023
-
EBITDA
Not available
-
Total Equity Funding
$20 M (USD)
in 1 rounds
-
Latest Funding Round
$20 M (USD), Series A
Dec 30, 2014
- Investors
-
Employee Count
Not available
-
Investments & Acquisitions
Arbor pharma
& 3 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Azurity Pharmaceuticals
Azurity Pharmaceuticals offers a comprehensive portfolio of products and services, including XIFYRM and FIRVANQ.
An IV non-steroidal anti-inflammatory drug is offered for the management of moderate-to-severe pain in adults
A product is provided for treating bacterial infections, forming part of the company's diversified pharmaceutical offerings
Funding Insights of Azurity Pharmaceuticals
Azurity Pharmaceuticals has successfully raised a total of $20M through 1 strategic funding round. The most recent funding activity was a Series A round of $20 million completed in December 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Azurity Pharmaceuticals
Azurity Pharmaceuticals has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Ampersand Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Ampersand Capital Partners is focused on investments in healthcare and life sciences.
|
Locked | Locked | Locked |
Investor details for Azurity Pharmaceuticals
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Azurity Pharmaceuticals
Azurity Pharmaceuticals has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Arbor pharma, Covis Pharma and Silvergate Pharma.
Investment portfolio details for Azurity Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Pharmaceutical company that markets therapeutic solutions for patients with life-threatening conditions and chronic illnesses
|
Locked | Locked | 2011 | Locked | |
|
Specialty generic drugs are manufactured with focus on complex injectables.
|
Locked | Locked | 2011 | Locked | |
|
Pharmaceutical products for pediatric patients are manufactured by the company.
|
Locked | Locked | 2010 | Locked |
Complete acquisition details for Azurity Pharmaceuticals
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Azurity Pharmaceuticals
Detailed financials for Azurity Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Azurity Pharmaceuticals Comparisons
Peer comparison for Azurity Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Azurity Pharmaceuticals
Detailed competitors of Azurity Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Azurity Pharmaceuticals
Complete news archive for Azurity Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Azurity Pharmaceuticals
Azurity Pharmaceuticals was founded in 1999 and raised its 1st funding round 15 years after it was founded.
Azurity Pharmaceuticals is headquartered in Woburn, United States. It is registered at Woburn, Massachusetts, United States.
Azurity Pharmaceuticals is a funded company, having raised a total of $20M across 1 funding round to date.
Annual revenue of Azurity Pharmaceuticals is $64.85K as on Jul 26, 2023.
Azurity Pharmaceuticals was founded in 1999 and is headquartered in Woburn, United States. Operations are conducted in the pharmaceutical sector, with a focus on the production of generic drugs. Manufacturing processes are centered on developing and supplying affordable medications to meet market needs. The companys domain, azurity.com, supports its digital operations and information dissemination. Geographic activities remain primarily within the United States.
Azurity Pharmaceuticals offers XIFYRM and FIRVANQ.
Azurity Pharmaceuticals has made 4 acquisitions, including Arbor pharma, Covis Pharma, and Silvergate Pharma.
Azurity Pharmaceuticals has 1 investor. Key investors include Ampersand Capital Partners.